Search Results - Giuseppe Viale
- Showing 1 - 20 results of 35
- Go to Next Page
-
1
The “lows”: Update on ER-low and HER2-low breast cancer by Nicola Fusco, Giuseppe Viale
Published in Breast (2024-12-01)Get full text
Article -
2
-
3
Standard operating procedures for biobank in oncology by Giuseppina Bonizzi, Lorenzo Zattoni, Lorenzo Zattoni, Maria Capra, Cristina Cassi, Giulio Taliento, Mariia Ivanova, Elena Guerini-Rocco, Elena Guerini-Rocco, Marzia Fumagalli, Massimo Monturano, Adriana Albini, Giuseppe Viale, Giuseppe Viale, Giuseppe Viale, Roberto Orecchia, Nicola Fusco, Nicola Fusco, Nicola Fusco
Published in Frontiers in Molecular Biosciences (2022-08-01)Get full text
Article -
4
Incorporating clinicopathological and molecular risk prediction tools to improve outcomes in early HR+/HER2– breast cancer by Giuseppe Curigliano, Rebecca Dent, Antonio Llombart-Cussac, Mark Pegram, Lajos Pusztai, Nicholas Turner, Giuseppe Viale
Published in npj Breast Cancer (2023-06-01)Get full text
Article -
5
PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer by Nicola Fusco, Nicola Fusco, Umberto Malapelle, Matteo Fassan, Matteo Fassan, Caterina Marchiò, Caterina Marchiò, Simonetta Buglioni, Simonetta Zupo, Carmen Criscitiello, Carmen Criscitiello, Paolo Vigneri, Paolo Vigneri, Angelo Paolo Dei Tos, Angelo Paolo Dei Tos, Eugenio Maiorano, Giuseppe Viale, Giuseppe Viale
Published in Frontiers in Oncology (2021-03-01)Get full text
Article -
6
Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature Review by Carmine Valenza, Francesca Maria Porta, Alessandra Rappa, Elena Guerini-Rocco, Giuseppe Viale, Massimo Barberis, Filippo de Marinis, Giuseppe Curigliano, Chiara Catania
Published in Current Oncology (2021-08-01)Get full text
Article -
7
-
8
Pre‐clinical validation of a selective anti‐cancer stem cell therapy for Numb‐deficient human breast cancers by Daniela Tosoni, Sarah Pambianco, Blanche Ekalle Soppo, Silvia Zecchini, Giovanni Bertalot, Giancarlo Pruneri, Giuseppe Viale, Pier Paolo Di Fiore, Salvatore Pece
Published in EMBO Molecular Medicine (2017-03-01)Get full text
Article -
9
Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis by Elham Sajjadi, Elham Sajjadi, Konstantinos Venetis, Konstantinos Venetis, Mariia Ivanova, Marianna Noale, Concetta Blundo, Eugenia Di Loreto, Giovanna Scarfone, Stefano Ferrero, Stefano Ferrero, Stefania Maggi, Paolo Veronesi, Paolo Veronesi, Viviana E. Galimberti, Giuseppe Viale, Giuseppe Viale, Fedro A. Peccatori, Nicola Fusco, Nicola Fusco, Elena Guerini-Rocco, Elena Guerini-Rocco
Published in Frontiers in Oncology (2023-08-01)Get full text
Article -
10
Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer by Luca Gianni, Marco Colleoni, Giancarlo Bisagni, Mauro Mansutti, Claudio Zamagni, Lucia Del Mastro, Stefania Zambelli, Giampaolo Bianchini, Antonio Frassoldati, Ilaria Maffeis, Pinuccia Valagussa, Giuseppe Viale
Published in npj Breast Cancer (2022-01-01)Get full text
Article -
11
Development and validation of a gene expression-based Breast Cancer Purity Score by Marco Barreca, Matteo Dugo, Barbara Galbardi, Balázs Győrffy, NA-PHER2 consortium, NeoTRIP consortium, Pinuccia Valagussa, Daniela Besozzi, Giuseppe Viale, Giampaolo Bianchini, Luca Gianni, Maurizio Callari
Published in npj Precision Oncology (2024-10-01)Get full text
Article -
12
Corrigendum: TMEM123 a key player in immune surveillance of colorectal cancer by Elisa Pesce, Chiara Cordiglieri, Mauro Bombaci, Serenella Eppenberger-Castori, Stefania Oliveto, Cristina Manara, Mariacristina Crosti, Caner Ercan, Mairene Coto, Andrea Gobbini, Susanna Campagnoli, Tiziano Donnarumma, Manuele Martinelli, Valeria Bevilacqua, Elisa De Camilli, Paola Gruarin, Maria L. Sarnicola, Elisa Cassinotti, Ludovica Baldari, Giuseppe Viale, Giuseppe Viale, Stefano Biffo, Stefano Biffo, Sergio Abrignani, Sergio Abrignani, Luigi M. Terracciano, Luigi M. Terracciano, Renata Grifantini, Renata Grifantini
Published in Frontiers in Immunology (2023-07-01)Get full text
Article -
13
The molecular landscape of breast mucoepidermoid carcinoma by Konstantinos Venetis, Elham Sajjadi, Mariia Ivanova, Silvia Andaloro, Simona Pessina, Chiara Zanetti, Alberto Ranghiero, Gabriele Citelli, Chiara Rossi, Marco Lucioni, Umberto Malapelle, Fabio Pagni, Massimo Barberis, Elena Guerini‐Rocco, Giuseppe Viale, Nicola Fusco
Published in Cancer Medicine (2023-05-01)Get full text
Article -
14
Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group T... by Kevin H. Kensler, Meredith M. Regan, Yujing J. Heng, Gabrielle M. Baker, Michael E. Pyle, Stuart J. Schnitt, Aditi Hazra, Roswitha Kammler, Beat Thürlimann, Marco Colleoni, Giuseppe Viale, Myles Brown, Rulla M. Tamimi
Published in Breast Cancer Research (2019-02-01)Get full text
Article -
15
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers by Florentine S. Hilbers, Coralie Poncet, Konstantinos Tryfonidis, Giuseppe Viale, Suzette Delaloge, Jean-Yves Pierga, Etienne G. C. Brain, Isabel T. Rubio, Alastair M. Thompson, Emiel J. T. Rutgers, Martine J. Piccart, Laura J. van ’t Veer, Fatima Cardoso
Published in npj Breast Cancer (2024-11-01)Get full text
Article -
16
Phase II study (KAMELEON) of single‐agent T‐DM1 in patients with HER2‐positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma by Elisabeth G. E. deVries, Josef Rüschoff, Martijn Lolkema, Josep Tabernero, Luca Gianni, Emile Voest, Derk Jan A. deGroot, Daniel Castellano, Gilles Erb, Julia Naab, Margarita Donica, Regula Deurloo, Michiel S. van derHeijden, Giuseppe Viale
Published in Cancer Medicine (2023-06-01)Get full text
Article -
17
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer by Tamar Zahavi, Mali Salmon-Divon, Roberto Salgado, Michael Elkin, Esther Hermano, Ariel M. Rubinstein, Prudence A. Francis, Angelo Di Leo, Giuseppe Viale, Evandro de Azambuja, Lieveke Ameye, Christos Sotiriou, Asher Salmon, Nataly Kravchenko-Balasha, Amir Sonnenblick
Published in npj Breast Cancer (2021-05-01)Get full text
Article -
18
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical t... by Laura Pala, Tommaso De Pas, Eleonora Pagan, Isabella Sala, Chiara Catania, Emma Zattarin, Paolo Arnone, Massimo M. Grassi, Marco Colleoni, Antonio C. Wolff, Javier Cortes, Martine Piccart, Richard D. Gelber, Giuseppe Viale, Vincenzo Bagnardi, Fabio Conforti
Published in Breast (2023-06-01)Get full text
Article -
19
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial by Mattia Rediti, David Venet, Andrea Joaquin Garcia, Marion Maetens, Delphine Vincent, Samira Majjaj, Sarra El-Abed, Serena Di Cosimo, Takayuki Ueno, Miguel Izquierdo, Martine Piccart, Lajos Pusztai, Sherene Loi, Roberto Salgado, Giuseppe Viale, Françoise Rothé, Christos Sotiriou
Published in Nature Communications (2024-11-01)Get full text
Article -
20
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for <i>PIK3CA</i> Testing in HR+/HER2− Breast Cancer by Konstantinos Venetis, Francesco Pepe, Elisabetta Munzone, Elham Sajjadi, Gianluca Russo, Pasquale Pisapia, Mariia Ivanova, Giuseppina Bonizzi, Davide Vacirca, Alessandra Rappa, Alberto Ranghiero, Sergio Vincenzo Taormina, Giuseppe Viale, Giancarlo Troncone, Massimo Barberis, Elena Guerini-Rocco, Umberto Malapelle, Nicola Fusco
Published in Cells (2022-11-01)Get full text
Article
